QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 abiomed-announces-fda-approves-impella-ecp-pivotal-heart-pump-and-first-patients-enrolled-in-pivotal-clinical-trial

Abiomed (NASDAQ:ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP th...

Core News & Articles

S&P MidCap 400 constituent Steel Dynamics Inc. (NASD:STLD) will replace Abiomed Inc. (NASD:ABMD) in the S&P 500 and Sup...

 pfizer-novartis-are-among-overbought-healthcare-stocks-are-they-worth-a-look

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s t...

Core News & Articles

Johnson & Johnson (NYSE: JNJ), the world's largest, most diversified healthcare products company, today announced that ...

 fda-says-on-dec-5-approved-updated-labeling-for-the-impella-rp-system-based-on-the-pas-results-with-an-update-to-the-indications-for-use-statement

- Reuters

 peering-into-abiomeds-recent-short-interest

Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it...

 heres-how-much-100-invested-in-abiomed-20-years-ago-would-be-worth-today

Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average...

 5-analysts-have-this-to-say-about-abiomed

Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically e...

 benzingas-top-ratings-upgrades-downgrades-for-november-2-2022

Upgrades

 morgan-stanley-upgrades-abiomed-to-equal-weight-raises-price-target-to-380

Morgan Stanley analyst Cecilia Furlong upgrades Abiomed (NASDAQ:ABMD) from Underweight to Equal-Weight and raises the price ...

 deutsche-bank-downgrades-abiomed-to-hold-raises-price-target-to-388

Deutsche Bank analyst Pito Chickering downgrades Abiomed (NASDAQ:ABMD) from Buy to Hold and raises the price target from $35...

 why-harsco-shares-surged-over-22-here-are-80-biggest-movers-from-yesterday

Gainers

 gartner-sony-uber-and-other-big-gainers-from-tuesday

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks ...

 william-blair-downgrades-abiomed-to-market-perform

William Blair analyst Margaret Kaczor downgrades Abiomed (NASDAQ:ABMD) from Outperform to Market Perform.

 what-to-watch-in-the-sp-biotech-etf-after-johnson--johnsons-166b-abiomed-deal

As the exodus out of mega-cap technology stocks continues, investors and money managers are looking for other sectors to rotate...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION